(19)
(11) EP 2 125 890 A2

(12)

(88) Date of publication A3:
18.12.2008

(43) Date of publication:
02.12.2009 Bulletin 2009/49

(21) Application number: 08713167.8

(22) Date of filing: 18.01.2008
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
G01N 33/53(2006.01)
G01N 33/573(2006.01)
C12N 5/12(2006.01)
C07K 16/40(2006.01)
G01N 33/566(2006.01)
G01N 33/68(2006.01)
(86) International application number:
PCT/US2008/000639
(87) International publication number:
WO 2008/091535 (31.07.2008 Gazette 2008/31)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 19.01.2007 US 881190 P

(71) Applicant: Biogen Idec MA Inc.
Cambridge, Massachusetts 02142 (US)

(72) Inventors:
  • GORELIK, Leonid
    Quincy, MA 02171 (US)
  • BAKER, Darren, P.
    Hingham, MA 02043 (US)
  • HESSION, Catherine, A.
    Hingham, MA 02043 (US)
  • VAN DE MARK, Karyn
    Woburn, MI 01801 (US)
  • ARDUNINI, Robert, M.
    Charlestown, MA 02129 (US)
  • WILDES, Craig
    Cambridge, MA 02142 (US)

(74) Representative: Adams, Harvey Vaughan John et al
Mathys & Squire LLP 120 Holborn
London EC1N 2SQ
London EC1N 2SQ (GB)

   


(54) ANTIBODIES TO PHOSPHORYLATED-IRAK4